Skip to main content
. 2016 Mar 22;10:73. doi: 10.3389/fncel.2016.00073

Table 1.

Antibodies used in this study.

Antibody Source Dilution
Primary antibodies
Goat anti-Calretinin Swant, Switzerland; CG1 1:1000
Guinea Pig anti-CGRP Peninsula Labs, San Carlos, CA, USA; T-5053 1:500
Chicken anti-GFAP Abcam, Cambridge, MA, USA; ab4674 1:1000
HuC/D Biotinylated Invitrogen, Carlsbad, CA, USA; A-21272 1:200
Sheep anti-nNos Millipore, Darmstadt, Germany; ab1529 1:500
Rabbit anti-Sirt3 Millipore, Darmstadt, Germany; 07-1596 1:100
Rabbit anti-Sirt3 Cell Signaling, Danvers, MA, USA; 5490 1:200
Rabbit anti-Sirt3 Abcam, Cambridge, MA, USA; Ab86671 1:200
Secondary antibodies
Donkey anti-Rabbit 488 Jackson, Bay Harbor, ME, USA; 711-545-152 1:400
Goat anti-Rabbit 488 Lifetech, Carlsbad, CA, USA; A-11034 1:400
Streptavidin 488 Jackson, Bay Harbor, ME, USA; 016-540-084 1:400
Donkey anti-Goat 568 Invitrogen, Carlsbad, CA, USA; A-11057 1:400
Donkey anti-Sheep 568 Invitrogen, Carlsbad, CA, USA; A-21099 1:400
Goat anti-Chicken 568 Invitrogen, Carlsbad, CA, USA; A-11041 1:400
Donkey anti-Guinea Pig 594 Jackson, Bay Harbor, ME, USA; 706-585-148 1:400
Streptavidin 594 Jackson, Bay Harbor, ME, USA; 016-580-084 1:400